| Literature DB >> 30833584 |
Zhenghe Wang1, Jieyun Song1, Yanhui Li1, Bin Dong1, Zhiyong Zou2, Jun Ma3.
Abstract
We examined the association between the China famine exposure in early life and DNA methylation of INSR (hg18, chr19:7110130-7110574) and CPT1A (hg18, chr11: 68286513-68286952) related to growth and metabolism in 235 subjects selected from two provinces in China. The subjects were categorized into prenatal famine-exposed group and non-exposed group based on their birthdates. DNA methylation at the INSR gene locus was assayed from peripheral white blood cells using the Sequenom's MassARRAY system. Two dependent samples t-test was used to compare the difference between the exposed group and non-exposed group. DNA methylation level of INSR was higher among individuals who exposed to the China famine in the fetus than that of non-exposed group (d = 3.3%, P = 0.006). A significant interaction between famine exposure and province was observed for INSR (Pinteraction < 0.001). DNA methylation level of INSR was positively associated with triglyceride (β = 0.011, P = 0.021), and negatively associated with high-density lipoprotein cholesterol (β = -0.039, P = 0.021). Moreover, exposed group had higher meat consumption than non-exposed group in severe exposure area. Prenatal exposure to the China famine plus later life eating habits might regulate epigenome.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30833584 PMCID: PMC6399294 DOI: 10.1038/s41598-019-38596-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow chart on the subjects selecting methods at each step.
The basic characteristics of study population.
| Variables | Exposed group (n = 75) | Non-exposed group (n = 160) |
| |
|---|---|---|---|---|
| Age (mean ± SD), years | 55.1 (0.8) | 54.6 (2.6) | 1.45 | 0.149 |
| Height (mean ± SD), cm | 160.79 (7.77) | 160.86 (8.29) | 0.06 | 0.949 |
| Weight (mean ± SD), kg | 63.27 (10.1) | 62.77 (10.83) | 0.36 | 0.720 |
| WC (mean ± SD), cm | 85.86 (10.57) | 82.97 (9.78) | 2.20 | 0.029 |
| BMI (mean ± SD), kg/m2 | 24.43 (3.2) | 24.27 (3.85) | 0.34 | 0.737 |
| FPG (mean ± SD), mmol/L | 6.12 (2.17) | 5.68 (1.41) | 1.69 | 0.094 |
| TG (mean ± SD), mmol/L | 1.78 (1.05) | 1.77 (1.13) | 0.08 | 0.932 |
| HDL-C (mean ± SD), mmol/L | 3.05 (0.89) | 2.87 (0.77) | 0.08 | 0.934 |
| LDL-C (mean ± SD), mmol/L | 1.27 (0.34) | 1.27 (0.33) | 1.64 | 0.102 |
| DBP (mean ± SD), mmHg | 83.1 (11.5) | 82.57 (10.55) | 0.37 | 0.710 |
| SBP (mean ± SD), mmHg | 127.92 (18.04) | 128.82 (17.24) | 0.39 | 0.694 |
| PA level n (%) | 1.281 | 0.258 | ||
| Non-vigorous | 69 (80.2) | 136 (73.9) | ||
| Vigorous | 17 (19.8) | 48 (26.1) | ||
| Meat n (%) | 0.227 | 0.634 | ||
| Non-daily | 54 (62.8) | 121 (65.8) | ||
| Every day | 32 (37.2) | 63 (34.2) | ||
| Vegetable n (%) | 1.933 | 0.164 | ||
| Non-daily | 8 (9.3) | 9 (4.9) | ||
| Every day | 78 (90.7) | 175 (95.1) | ||
| Fruit n (%) | 0.045 | 0.831 | ||
| Non-daily | 54 (62.8) | 118 (64.1) | ||
| Every day | 32 (37.2) | 66 (35.9) | ||
| Milk n (%) | 0.000 | 0.983 | ||
| Non-daily | 73 (84.9) | 156 (84.8) | ||
| Every day | 13 (15.1) | 28 (15.2) | ||
| Smoking n (%) | 1.047 | 0.306 | ||
| <400 cigarettes | 52 (60.5) | 123 (66.8) | ||
| ≥400 cigarettes | 34 (39.5) | 61 (33.2) | ||
| Drinking n (%) | 4.467 | 0.035 | ||
| <Once per month | 45 (52.3) | 121 (65.8) | ||
| ≥Once per month | 41 (47.7) | 63 (34.2) |
Abbreviations: WC, waist circumference; BMI, body mass index; FPG, fasting plasma glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; DBP, diastolic blood pressure; SBP, systolic blood pressure; PA, physical activity.
Independent-samples t-test was used to compare difference of continuous variables between exposed group and non-exposed group, and Chi-square test was used to compare the difference of categorized variables between exposed group and no-exposed group.
The comparison of basic characteristics of study population stratified by areas.
| Variables | Anhui | Jiangxi | ||
|---|---|---|---|---|
| Non-exposed group | Exposed group | Non-exposed group | Exposed group | |
| Age (mean ± SD), years | 54.9 (2.7) | 55.3 (0.6) | 54.5 (2.6) | 54.8 (0.9) |
| Height (mean ± SD), cm | 160.93 (7.66) | 160.83 (7.71) | 160.13 (8.76) | 160.75 (8.15) |
| Weight (mean ± SD), kg | 65.21 (10.52) | 66.15 (9.65) | 60.21 (10.86) | 60.11 (9.74) |
| WC (mean ± SD), cm | 84.51 (9.91) | 87.56 (8.44)* | 81.83 (9.51) | 83.98 (12.34) |
| BMI (mean ± SD), kg/m2 | 25.11 (3.19) | 25.53 (2.95) | 23.56 (4.35) | 23.22 (3.06) |
| FPG (mean ± SD), mmol/L | 5.96 (1.26) | 6.70 (2.28)* | 5.42 (1.53) | 5.47 (1.87) |
| TG (mean ± SD), mmol/L | 1.83 (1.19) | 2.04 (1.23) | 1.73 (1.08) | 1.49 (0.73) |
| HDL-C (mean ± SD), mmol/L | 1.37 (0.34) | 1.33 (0.37) | 1.17 (0.28) | 1.20 (0.31) |
| LDL-C (mean ± SD), mmol/L | 3.12 (0.80) | 3.35 (0.93) | 2.62 (0.66) | 2.71 (0.70) |
| DBP(mean ± SD), mmHg | 86.93 (8.49) | 87.36 (9.70) | 77.61 (10.29) | 78.31 (11.60) |
| SBP (mean ± SD), mmHg | 136.88 (16.13) | 136.78 (14.55) | 120.53 (14.42) | 117.95 (16.42) |
| PA level n (%) | ||||
| Vigorous | 74 (82.2) | 40 (88.9) | 59 (67.0) | 29 (70.7) |
| Non-vigorous | 16 (17.8) | 5 (11.1) | 29 (33.0) | 12 (29.3) |
| Meat n (%) | ||||
| Non-daily | 58 (64.4) | 24 (53.3) | 59 (67.0) | 30 (73.2) |
| Every day | 32 (35.6) | 21 (46.7) | 29 (33.0) | 11 (26.8) |
| Vegetable n (%) | ||||
| Non-daily | 2 (2.2) | 3 (6.7) | 7 (8.0) | 5 (12.2) |
| Every day | 88 (97.8) | 42 (93.3) | 81 (92.0) | 36 (87.8) |
| Fruit n (%) | ||||
| Non-daily | 50 (55.6) | 22 (48.9) | 62 (70.5) | 32 (78.0) |
| Every day | 40 (44.4) | 23 (51.1) | 26 (29.5) | 9 (22.0) |
| Milk n (%) | ||||
| Non-daily | 73 (81.1) | 38 (84.4) | 78 (88.6) | 35 (85.4) |
| Every day | 17 (18.9) | 7 (15.6) | 10 (11.4) | 6 (14.6) |
| Smoking n (%) | ||||
| <400 cigarettes | 58 (64.4) | 27 (60.0) | 65 (73.9) | 25 (61.0) |
| ≥400 cigarettes | 32 (35.6) | 18 (40.0) | 23 (26.1) | 16 (39.0) |
| Drinking n (%) | ||||
| <Once per month | 56 (62.2) | 19 (42.2) | 63 (71.6) | 26 (63.4) |
| ≥Once per month | 34 (37.8) | 26 (57.8)* | 25 (28.4) | 15 (36.6) |
Abbreviations: WC, waist circumference; BMI, body mass index; FPG, fasting plasma glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; DBP, diastolic blood pressure; SBP, systolic blood pressure; PA, physical activity.
Independent-samples t-test was used to compare difference of continuous variables between exposed group and non-exposed group, and Chi-square test was used to compare the difference of categorized variables between exposed group and no-exposed group. *Represents P < 0.05.
DNA methylation (%) and fetal stage exposure to famine
| Genes locus | Exposed group (n = 75) | Non-exposed group (n = 160) |
| Effect size | ||
|---|---|---|---|---|---|---|
|
| 46.7 ± 7.0 | 43.4 ± 9.2 | 3.3 | 0.20 | 0.003 | 0.006 |
|
| 44.1 ± 7.8 | 45.5 ± 8.8 | −1.4 | −0.08 | 0.605 | NSd |
Abbreviations: INSR, insulin receptor; CPT1A, carnitine palmitoyltransferase 1A.
aAverage absolute difference in DNA methylation between exposed group and non-exposed group.
bLinear regression models were used to compare the difference between exposed group and non-exposed group.
cBonferroni-corrected P-value.
dNo significance.
Figure 2DNA methylation difference between fetal-exposed group and non-exposed group at each CpG unit of the loci INSR. The amplicon comprised 9 CpG sites at the INSR differential methylation region in Human Genome 18 assembly- chr19: 7,110,130-chr 19: 7,110,574 (NCBI 36/hg18). The location of each CpG site was listed below: CpG1:7,110,208; CpG2: 7,110,217; CpG3: 7,110,260; CpG4: 7,110,345; CpG5: 7,110,361; CpG6: 7,110,389; CpG7: 7,110,423; CpG8: 7,110,454; CpG9: 7,110,540. Independent-samples t-test to compare the DNA methylation difference between exposed group and non-exposed group. **Presents P < 0.01, ***presents P < 0.001.
Figure 3DNA methylation difference between fetal-exposed group and non-exposed group at each CpG unit of the loci CPT1A. The amplicon comprised 9 CpG sites at the INSR differential methylation region in Human Genome 18 assembly- chr11: 68,286,513 - chr11: 68,286,952 (NCBI 36/hg18). The location of each CpG site was listed below: CpG1: 68,286,641; CpG2&3: 68,286,671&68,286,680; CpG4: 68,286,696; CpG6: 68,286,706; CpG7: 68,286,729; CpG11: 68,286,762; CpG12: 68,286,778; CpG13: 68,286,833; CpG15: 68,286,894; CpG16: 68,286,925. Independent-samples t-test to compare the DNA methylation difference between exposed group and non-exposed group.
DNA methylation and fetal stage exposure to famine stratified by region.
| Genes locus | Exposed group | Non-exposed group |
| Effect size | ||
|---|---|---|---|---|---|---|
|
| ||||||
| Anhui | 46.2 ± 4.7 | 43.5 ± 7.4 | 2.6 | 0.21 | 0.018 | <0.001 |
| Jiangxi | 47.3 ± 9.1 | 43.3 ± 10.9 | 4.0 | 0.20 | 0.062 | |
|
| ||||||
| Anhui | 44.6 ± 7.4 | 46.8 ± 7.6 | −2.2 | −0.15 | 0.141 | 0.926 |
| Jiangxi | 41.2 ± 10.0 | 43.9 ± 10.0 | −2.7 | −0.13 | 0.548 | |
Abbreviations: INSR, insulin receptor; CPT1A, carnitine palmitoyltransferase 1A.
aAverage absolute difference in DNA methylation between exposed group and non-exposed group.
bIndependent-samples t-test to compare the difference between exposed group and non-exposed group.
cInteraction analysis between region and famine exposure.
The associations of main phenotypes with the DNA methylation.
| Indicators |
|
| ||||
|---|---|---|---|---|---|---|
|
|
| P-value |
|
| ||
| BMI | 0.000 | <0.001 | 0.851 | −0.003 | 0.006 | 0.132 |
| WC | 0.000 | 0.001 | 0.596 | −0.001 | 0.009 | 0.189 |
| FPG | 0.003 | 0.002 | 0.466 | 0.000 | <0.001 | 0.913 |
| TG |
|
|
| −0.004 | 0.003 | 0.452 |
| LDL-C | −0.007 | 0.005 | 0.271 | −0.006 | 0.003 | 0.446 |
| HDL-C |
|
|
| 0.031 | 0.015 | 0.079 |
| DBP | 0.000 | <0.001 | 0.892 | 0.000 | 0.002 | 0.513 |
| SBP | 0.000 | 0.001 | 0.608 | 0.000 | 0.001 | 0.673 |
Abbreviations: BMI, Body mass index; WC, Waist circumstance; FPG, Fasting plasma glucose; TG, Triglyceride; LDL-C, Low density lipoprotein cholesterol; HDL-C, High density lipoprotein cholesterol; DBP, Diastolic blood pressure; SBP, Systolic blood pressure; INSR, Insulin receptor; CPT1A, carnitine palmitoyltransferase 1A; IGF2, insulin growth factor 2. β, regression coefficients from linear regression models. R, coefficient of determination; Significant associations were depicted in bold print. Linear regression was used to analyze the associations between DNA methylation and main phenotypes.